Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy

NCT05699460 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-10-02

No results posted yet for this study

Summary

The objective of this study is to describe disease progression in study participants diagnosed with early Parkinson's Disease or Multiple System Atrophy - Parkinsonian Type up to 18 months as delineated by clinical and biochemical parameters.

Conditions

Interventions

OTHER

This is an observational study.

This is an observational study.

Sponsors & Collaborators

  • AskBio Inc

    lead INDUSTRY

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-29
Primary Completion
2025-11-30
Completion
2025-11-30

Countries

  • United States
  • Poland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05699460 on ClinicalTrials.gov